New X-ray Tech Speeds Tissue Analysis & Improves Diagnosis | UCL Research

A new X-ray imaging technique promises a significant leap forward in how hospitals analyze tissue samples, potentially accelerating diagnoses and improving patient outcomes. The technology, developed by researchers at University College London (UCL) in collaboration with the Memorial Sloan Kettering Cancer Center, Rigaku Americas, and Creatv MicroTech, Inc., creates detailed three-dimensional images of biological tissue without the need for traditional cutting and staining processes.

The conventional method of examining tissue – known as histopathology – is crucial for studying, diagnosing, and treating diseases, particularly cancer. However, it’s a time-consuming process. Preparing samples for histopathology involves fixing, embedding, sectioning, and staining the tissue, all of which can introduce delays and potential artifacts. This new technique bypasses those steps, offering a potentially faster and more accurate way to visualize tissue structure at a subcellular level.

The Promise of Label-Free Imaging

Currently, histopathology relies heavily on staining techniques to highlight different cellular components. While effective, staining can alter the tissue and may not always reveal the complete picture. This new X-ray imaging method, described in a recent study published in PNAS, offers a “label-free” approach. It leverages the natural contrast within the tissue itself, allowing researchers to generate high-resolution 3D maps without any chemical treatments. This is achieved through a laboratory-based multi-modal X-ray microscope.

The research team, led by Michela Esposito of UCL’s Department of Medical Physics and Biomedical Engineering, demonstrated the technique’s ability to visualize unstained soft tissue with remarkable detail. The study, too available as a preprint on medRxiv, highlights the potential for quicker and more objective assessments of tissue samples.

How Does It Work? X-ray Phase Contrast Imaging

The technique builds upon a concept called X-ray phase contrast imaging (XPCI). Traditional X-ray imaging relies on differences in X-ray attenuation – how much the X-rays are absorbed by the tissue. XPCI, however, exploits variations in the phase of the X-rays as they pass through the sample. This is particularly useful for visualizing soft tissues, which have low attenuation and are often tough to see with conventional X-rays. As explained by the Advanced X-Ray Imaging Group (AXIm) at UCL, XPCI can reveal details previously considered “x-ray invisible.”

Most XPCI methods require specialized facilities called synchrotrons, which are large and expensive. A key innovation of this research is the development of a system that can perform XPCI using conventional, laboratory-based X-ray sources, making the technology more accessible to hospitals and research institutions.

Who Stands to Benefit?

The immediate impact of this technology is likely to be felt in pathology labs, where it could streamline the diagnostic process for a wide range of conditions. Cancer diagnosis is a primary application, but the technique could also be valuable in studying other diseases affecting soft tissues, such as inflammatory conditions and neurological disorders. The ability to visualize tissue structure in 3D without staining could also aid in drug discovery and development, allowing researchers to assess the effects of new therapies more accurately.

Researchers involved in the study include individuals from Memorial Sloan Kettering Cancer Center in New York, where Alexei Teplov is based in the Department of Pathology & Lab Medicine. This collaboration underscores the potential for widespread adoption of the technology within leading cancer centers.

Evidence and Limitations: What the Study Shows (and Doesn’t)

The PNAS study demonstrates the feasibility of this technique on a range of tissue samples. However, it’s important to note that this is still early-stage research. The study focused on demonstrating the imaging capabilities of the system; further research is needed to validate its accuracy and reliability in a clinical setting. The researchers acknowledge that more work is needed to optimize the technique for different tissue types and to develop automated image analysis tools.

The study does not yet provide data on how this technique compares to histopathology in terms of diagnostic accuracy or turnaround time. It also doesn’t address the cost-effectiveness of the technology. While the leverage of a laboratory-based X-ray source reduces the need for expensive synchrotron facilities, the initial investment in the specialized microscope and associated equipment could be substantial.

What Comes Next: From Lab to Clinic

The next steps involve conducting larger-scale studies to evaluate the clinical utility of the technique. Researchers will need to compare the results obtained with this new X-ray imaging method to those obtained with traditional histopathology, assessing its accuracy, sensitivity, and specificity. They will also need to develop standardized protocols for image acquisition and analysis to ensure reproducibility.

Further research will focus on refining the technique to improve image resolution and contrast, and to expand its applicability to a wider range of tissue types. The team is also exploring the potential for integrating this technology with other imaging modalities, such as optical microscopy, to provide a more comprehensive view of tissue structure and function.

the goal is to translate this research into a practical tool that can be used in hospitals and pathology labs to improve patient care. The researchers are actively seeking collaborations with clinicians and industry partners to accelerate the development and commercialization of this promising new technology.